Liu and colleagues showed that heterozygous mutant ATP2A2 mice develop late-onset squamous cell tumors in the gut and in the skin where the expression of SERCA2 protein is reduced due to haploinsufficient loss-of-function mutations [93]. Here, ATP2A2 is linked to squamous cell neoplasm.